AbbVie, Iambic collaborate on AI-driven drug discovery
AbbVie Inc. and Iambic have announced a collaboration aimed at accelerating small molecule drug discovery in immunology, neuroscience, and oncology using AI. Iambic will receive an upfront payment, milestone payments, and tiered royalties from the collaboration.